New drug for treatment of prostate cancer
The current treatment for prostate cancer is to limit the activity of male hormones because these hormones cause tumors to grow.
Recently, researchers at the University of California have introduced the MDV3100 drug to treat prostate cancer according to a completely different solution. This drug will prevent tumor cells from absorbing male hormones.
Doctors at Memorial Sloan-Kettering Cancer Center tested the drug MDV3100 in 30 patients with severe prostate cancer who were resistant to current treatment drugs. After treatment, blood levels of Prostate Specific Antigen (PSA-specific prostate) were reduced in 13 patients (43%). Doctors consider this a very promising result.
Based on the results of the study, pharmaceutical company Medivation is submitting to the US Food and Drug Administration for extensive testing of the drug.
- Genetic testing supports prostate cancer treatment
- New step in the treatment of prostate cancer
- Estrogen patches treat prostate cancer
- New treatment for prostate cancer
- Drug Digitalis has the ability to fight prostate cancer
- For the first time, implant successful cancer treatment beads in Vietnam
- Explosive ingredients can destroy prostate tumors
- Breakthrough in the treatment of prostate cancer
- New drugs Asentar treat prostate cancer
- New discovery about prostate cancer treatment
Eastern flower fragrance prevents prostate cancer Dogs can detect prostate cancer How many times a month for men? Signs of men with prostate inflammation Continued urination and more than usual, signaling what disease? The fungus thoroughly cure prostate tumors Detects bacteria that cause infections Finger reveals risk of prostate cancer?